"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell line:ch1","tissue:ch1"
"GSM5036359","SH82K33 HCC-827 Exo-RNA","GSM5036359","Public on Jun 15 2021","Jan 26 2021","Jun 15 2021","RNA","1","primary lung cancer cell line","Homo sapiens","tissue: primary lung cancer cell line","cell line: SH82K33","total RNA","Exosomes were obtained from the culture supernatant of these cells by a centrifugal ultrafiltration-based method. Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) from  isolated exosomes.","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 32 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","HCC-827 cells (with a deletion in exon 19) were purchased from the American Type Culture Collection (Manassas, VA, USA) .","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL21263","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5036nnn/GSM5036359/suppl/GSM5036359_SH82K33_Cell1.txt.gz","2565","SH82K33","primary lung cancer cell line"
"GSM5036360","SH82K33 AZD-827 Exo-RNA","GSM5036360","Public on Jun 15 2021","Jan 26 2021","Jun 15 2021","RNA","1","primary lung cancer cell line","Homo sapiens","tissue: primary lung cancer cell line","cell line: SH82K33","total RNA","Exosomes were obtained from the culture supernatant of these cells by a centrifugal ultrafiltration-based method. Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) from  isolated exosomes.","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 32 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","Osimertinib-resistant HCC827 (AZD-827) cells were established using a stepwise method.","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL21263","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5036nnn/GSM5036360/suppl/GSM5036360_SH82K33_Cell2.txt.gz","2565","SH82K33","primary lung cancer cell line"
"GSM5036361","SH82K33 PC9 Exo-RNA","GSM5036361","Public on Jun 15 2021","Jan 26 2021","Jun 15 2021","RNA","1","primary lung cancer cell line","Homo sapiens","tissue: primary lung cancer cell line","cell line: SH82K33","total RNA","Exosomes were obtained from the culture supernatant of these cells by a centrifugal ultrafiltration-based method. Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) from  isolated exosomes.","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 32 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","PC9 cells (with a deletion in exon 19) were obtained from Immuno-Biological Laboratories (Gunma, Japan).","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL21263","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5036nnn/GSM5036361/suppl/GSM5036361_SH82K33_Cell3.txt.gz","2565","SH82K33","primary lung cancer cell line"
"GSM5036362","SH82K33 AZD-PC9 Exo-RNA","GSM5036362","Public on Jun 15 2021","Jan 26 2021","Jun 15 2021","RNA","1","primary lung cancer cell line","Homo sapiens","tissue: primary lung cancer cell line","cell line: SH82K33","total RNA","Exosomes were obtained from the culture supernatant of these cells by a centrifugal ultrafiltration-based method. Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) from  isolated exosomes.","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray, Kamakura, Japan)","9606","Hybridized for 16 h at 32 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","Osimertinib-resistant PC9 (AZD-PC9) cells were established using a stepwise method.","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL21263","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5036nnn/GSM5036362/suppl/GSM5036362_SH82K33_Cell4.txt.gz","2565","SH82K33","primary lung cancer cell line"
